EpiEndo Pharmaceuticals announces new partnership with Recipharm
EpiEndo Pharmaceuticals are proud to announce our new partnership with Recipharm, a Swedish Contract Development and Manufacturing Organisation (CDMO). EpiEndo and Recipharm will be collaborating in the synthesis of our novel compound, which will be led by Fredrik Lehman, our CMC Director and General Manager at Recipharm .
Recipharm was founded in 1995 and is one of the leading CDMOs in the industry. The company is listed on the Swedish stock exchange.